Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Array BioPharma
Pharma
Pfizer scores FDA nod for Braftovi duo in colon cancer
Will Pfizer's Braftovi-Erbitux combo in BRAF-mutated colon cancer be the standard of care? Adding Mektovi may be the real opportunity, some predict.
Arlene Weintraub
Apr 9, 2020 11:28am
How Merck's desire for more 'control' became a $2.7B ArQule buy
Dec 19, 2019 11:56am
AZ's struggling cancer drug nabs priority review in rare disease
Nov 14, 2019 11:30am
Pfizer eyes commercial scale-up as Array combo hits its marks
Sep 29, 2019 9:36pm
How one hot protein family is driving cancer drug deals: report
Aug 21, 2019 11:55am
With its generic spinoff cash, will Pfizer step up its buying game?
Jul 30, 2019 10:53am
